Results 51 to 60 of about 17,554 (214)

Oral nanoemulsions of candesartan cilexetil: formulation, characterization and in vitro drug release studies

, 2017
Nanoemulsion is considered to be a new and exciting field of research that seeks to exploit the attractive properties of components to improve oral delivery of drugs like candesartan cilexetil used in the management of chronic diseases.
H. H. Ali, A. Hussein
semanticscholar   +1 more source

Candesartan cilexetil/hydrochlorothiazide combination treatment versus high-dose candesartan cilexetil monotherapy in patients with mild to moderate cardiovascular risk (CHILI Triple T)

, 2011
Gerd Bönner1, Bernhard Landers2, Peter Bramlage31Park-Klinikum Bad Krozingen, Germany; 2Internal Medicine Practice, Diabetes Center, Mayen, Germany; 3Institute for Cardiovascular Pharmacology and Epidemiology, Mahlow, GermanyBackground: Candesartan ...
Landers B, Bonner G, Bramlage P
core  

Tinjauan Metode-Metode Analisis Candesartan Selama Tahun 2000-2020 [PDF]

, 2020
Antagonis reseptor angiotensin II tipe 1 telah banyak digunakan dalam pengobatan berbagai penyakit seperti hipertensi, gagal jantung, infark miokard, dan nefropati diabetes.
Adzimah, Mulkiyah, ADZIMAH MULKIYAH/1611012034   +1 more
core  

A Robust and Universal LC–MS/MS Method for Determination of N‐Nitrosodimethylamine in Pharmaceuticals Using a C30 Column

Journal of Separation Science, Volume 49, Issue 6, June 2026.
ABSTRACT Since the 2018 valsartan recall, the genotoxic impurity N‐nitrosodimethylamine (NDMA) has been frequently detected in various pharmaceuticals. Matrix variability often complicates routine testing, requiring customized analyses. We developed a universal LC–MS/MS method enabling consistent NDMA detection across diverse pharmaceuticals ...
Byungchan An, Unyong Kim, Sumin Seo, Jiyu Kim, Chohee Jeong, Woojin Jeong, Eunjin Ko, Juhyeon Kim, Hyun‐Deok Cho, Sang Beom Han   +9 more
wiley   +1 more source

No pharmacokinetic interactions between candesartan and amlodipine following multiple oral administrations in healthy subjects

, 2018
Jung-Ryul Kim,1,2 Seokuee Kim,1 Wooseong Huh,1,3 Jae-Wook Ko1 1Department of Clinical Pharmacology and Therapeutics, Samsung Medical Center, Republic of Korea; 2Department of Clinical Research Design & Evaluation, SAIHST, Sungkyunkwan University ...
Kim S, Ko JW, Kim JR, Huh W
core  

The development of type 2 diabetes amongst sibling pairs in the South‐South region of Nigeria: The effect of genetics, environment and lifestyle

Diabetic Medicine, Volume 43, Issue 6, June 2026.
Abstract Introduction Type 2 diabetes is a complex condition with a multifactorial pathogenesis. The pathogenesis is considered to be polygenic due to complex interactions between genetic/epigenetic and environmental factors. The aim of this study is to determine the genetic, environmental and lifestyle factors associated with the development of type 2
Sunny Chinenye, Ibi Erekosima, Adrian H. Heald, Gesiye Bozimo, Simon G. Anderson, Samuel Seidu, Kariba Akhidue, Adaeze Ugwu, Chioma Unachukwu, Ibitrokoemi Korubo, Kingsley Chukwuemeka Patrick‐Iwuanyanwu, Victoria Gomba, Uwoma Batubo, Victoria Akanatei, Victor Ken‐Uba, Iyeopu Siminialayi, Sokiprim Akoko, Justin Ideozu, Hamilton Opurum   +18 more
wiley   +1 more source

Effectiveness and acceptability of oral migraine preventives: A prospective, observational study

Headache: The Journal of Head and Face Pain, Volume 66, Issue 6, Page 1250-1262, June 2026.
Plain Language Summary Most knowledge about migraine preventive medicines comes from clinical trials, but less is known about their real‐world outcomes and side effects. We followed 254 people with migraine who started on commonly used oral migraine preventive drugs and tracked their results over 12 weeks.
Hedda S. Riise, Melanie R. Simpson, Ketil A. Espnes, Erling A. Tronvik, Andreas K. Husøy, Lise R. Øie, Anker Stubberud, Emil Kofoed, Aurora H. Alstad, Hedda H. Hagen, Maren G. Lien, Marie L. Stavseng, Ella R. Sæther, Tore Wergeland   +13 more
wiley   +1 more source

Differential clinical profile of candesartan compared to other angiotensin receptor blockers

, 2011
Relu Cernes1,2, Margarita Mashavi1,3, Reuven Zimlichman1,31The Brunner Institute for Cardiovascular Research, Wolfson Medical Center and Tel Aviv University, Tel Aviv, Israel; 2Department of Nephrology, Wolfson Medical Center, Holon, Israel; 3Department ...
Zimlichman R
core  

The Effect of Candesartan Alone and Its Combination With Estrogen on Post-traumatic Brain Injury Outcomes in Female Rats

Frontiers in Neuroscience, 2019
Aim: The aim of this study was to evaluate the effect of candesartan (angiotensin II type I receptor blocker) alone and its combination with estrogen on the changes in brain edema, intracranial pressure (ICP), and cerebral perfusion pressure (CPP ...
Mojdeh Hajmohammadi, M. Khaksari, Z. Soltani, N. Shahrokhi, H. Najafipour, R. Abbasi   +5 more
semanticscholar   +1 more source

Bioequivalence study of two formulations of candesartan cilexetil tablet in healthy subjects under fasting conditions

, 2013
Raymond R Tjandrawinata,1 Effi Setiawati,2 Danang Agung Yunaidi,2 Ronal Simanjuntak,2 Iwan Dwi Santoso,2 Liana W Susanto1 1Dexa Laboratories of Biomolecular Sciences (DLBS), Cikarang, Indonesia; 2Bioavailability and Bioequivalence Laboratory, PT Equilab ...
Tjandrawinata RR, Yunaidi DA, Susanto LW, Santoso ID, Setiawati E, Simanjuntak R   +5 more
core